Lysanxia



Indications and Reactions:

Role Indications Reactions
Secondary
Drug Use For Unknown Indication 24.2%
Product Used For Unknown Indication 22.3%
Bipolar I Disorder 17.0%
Depression 7.6%
Anxiety 7.2%
Bipolar Disorder 2.4%
Hepatitis C 2.0%
Multiple Sclerosis 1.7%
Insomnia 1.5%
Schizoaffective Disorder 1.5%
Dementia With Lewy Bodies 1.3%
Drug Toxicity 1.3%
Hiv Infection 1.3%
Neurosis 1.3%
Pain 1.3%
Parkinson's Disease 1.3%
Vaginitis Bacterial 1.3%
Abnormal Behaviour 1.1%
Cognitive Disorder 1.1%
Drug Abuse 1.1%
Thrombocytopenia 9.4%
Sudden Death 8.2%
Toxicity To Various Agents 8.2%
Haemorrhage 7.1%
Pulmonary Arterial Hypertension 7.1%
Speech Disorder 7.1%
Premature Baby 5.9%
Somnolence 5.9%
Drug Exposure During Pregnancy 4.7%
Intra-uterine Death 4.7%
Depression 3.5%
Limb Malformation 3.5%
Neuroleptic Malignant Syndrome 3.5%
Off Label Use 3.5%
Suicide Attempt 3.5%
Toxic Encephalopathy 3.5%
Vaginitis Gardnerella 3.5%
Cardio-respiratory Arrest 2.4%
Cholestasis 2.4%
Confusional State 2.4%
Concomitant
Product Used For Unknown Indication 22.9%
Depression 13.8%
Drug Use For Unknown Indication 13.3%
Anxiety 9.3%
Ill-defined Disorder 4.2%
Hypertension 3.9%
Bipolar Disorder 3.5%
Insomnia 3.3%
Rheumatoid Arthritis 2.8%
Schizophrenia 2.8%
Prophylaxis 2.7%
Parkinson's Disease 2.6%
Pain 2.5%
Psychotic Disorder 2.4%
Hiv Infection 2.1%
Bipolar I Disorder 2.0%
Type 2 Diabetes Mellitus 1.7%
Breast Cancer 1.6%
General Anaesthesia 1.5%
Back Pain 1.2%
Vertigo 14.3%
Weight Increased 7.1%
Tremor 6.5%
Vomiting 6.5%
Cytolytic Hepatitis 5.8%
Pulmonary Embolism 5.8%
Suicide Attempt 5.8%
Neutropenia 5.2%
Vascular Purpura 5.2%
Thrombocytopenia 4.5%
Weight Decreased 4.5%
Death 3.9%
Renal Failure 3.9%
Renal Failure Acute 3.9%
Suicidal Ideation 3.2%
White Blood Cell Count Decreased 3.2%
Hospitalisation 2.6%
Nausea 2.6%
Phlebitis 2.6%
Rash 2.6%
Interacting
Product Used For Unknown Indication 76.9%
Drug Use For Unknown Indication 15.4%
Abnormal Behaviour 5.1%
Acute Lymphocytic Leukaemia 2.6%
Traumatic Brain Injury 44.4%
Death 22.2%
Hypoxia 11.1%
Oral Disorder 11.1%
Toxicity To Various Agents 11.1%